Abstract
According to WHO, there will be epidemic of diabetes world over and India is going to be ‘A diabetes capital of the world’ by 2025. With the increasing incidence of diabetes, the associated complications are also bound to increase. Rhinocerebral mucormycosis is one of them.
Rhinocerebral Mucormycosis is an opportunistic, fulminating fungal infection, caused by Rhizopus species of order of mucorales, frequently seen in diabetic and immunocompromised patients. Mucormycosis has a very high mortality rate.
Early diagnosis and treatment with Amphotericin-B is the key to combat this disease successfully. We have seen 13 cases in last 3 years (2002–2005) in our area. This incidence is significant, as this type of cases were rarely seen before 2002, in this geographical area. We present an account of these cases; treatment strategies adopted, review of literature, and highlight ‘the role of ENT surgeon in diagnosis and management of this dreadful disease’.
Keywords: Rhinocerebral Mucormycosis, Mucormycosis, Complications of diabetes, Nasal Endoscopy
Full Text
The Full Text of this article is available as a PDF (125.7 KB).
Footnotes
This Paper was presented at MENTCON, 2005 Mumbai, and achieved best paper award in consultant category.
References
- 1.Suneetha N., Moire J., Ravindra B. Rhino-Orbito-Cerebral Mucormycosis. A retrospective Analysis of Clinical features and Treatment Outcomes. Indian Journal of Ophthalmology. 2003;51:231–236. [PubMed] [Google Scholar]
- 2.Seiff S.R., Choo P.H., Carter S.R. Role of local amphotericin B therapy for sino-orbital fungal infections. Ophthalmic Plastic and Reconstructive Surgery. 1999;15(1):28–31. doi: 10.1097/00002341-199901000-00007. [DOI] [PubMed] [Google Scholar]
- 3.Jiang Rs H. Endoscopic Sinus Surgery for Rhinocerebral Mucormycosis. American Journal of Rhinology Mar-Apr. 1999;13(2):105–109. doi: 10.2500/105065899782106751. [DOI] [PubMed] [Google Scholar]
- 4.Prevention of diabetes mellitus. Geneva: WHO; 1994. [Google Scholar]
- 5.Artiscolleagues Diabetes Dec. 1982;31(12):1109–1146. [Google Scholar]
- 6.Artiscolleagues Appl Environ Microbiol. 1976;32(3):381–7. doi: 10.1128/aem.32.3.381-387.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Vaid N. S., Athavale S. A., Kale O.S. Mucormycosis: A retrospective study, Indian Journal of Otolaryngology and Head and Neck Surgery. 2005;57-2:136–138. doi: 10.1007/BF02907668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Mondy K. E., Haughey B., Custer P. L., Wippold F. J., II, Ritchie D. J., Pharm D., Mundy L. M. Rhinocerebral Mucormycosis in the Era of Lipid-Based Amphotericin B: Case Report and Literature Review, Pharmacotherapy. 2002;22(4):519–526. doi: 10.1592/phco.22.7.519.33679. [DOI] [PubMed] [Google Scholar]